NeuroMetrix Announces Issuance of New U.S. Patent for Quell® Wearable Technology
(WorldNews Health)

PDF Version WOBURN, Mass., Sept. 21, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that the U.S. Patent and Trademark Office will issue on September 22, 2020 U.S. Patent No. 10,780,269 titled `Apparatus and Method for Relieving Pain Using Transcutaneous Electrical Nerve Stimulation.` The patent covers core Quell technology that regulates electrical stimulation based on the device orientation. No other wearable pain relief device has position dependent...